Clinical Trials Browser

Phase 3 × INDUSTRY × Squamous Non-Small Cell Lung Cancer × Clear all

NCT02367794 2022-03-21

A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131]

Phase 3 Completed

1,021 enrolled 33 charts

Squamous Non-Small Cell Lung Cancer